Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Curis Inc (CRIS)

Curis Inc (CRIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Curis: Q2 Earnings Snapshot AP - Fri Aug 14, 3:16PM CDT

Curis: Q2 Earnings Snapshot

CRIS : 1.6100 (-6.40%)
Curis, Inc. Announces Pricing of $5.6 Million Public Offering PR Newswire - Thu Aug 13, 7:00AM CDT

LEXINGTON, Mass. , Aug. 13, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 1.6100 (-6.40%)
Curis Doses First Five Patients in TakeAim CLL Study PR Newswire - Thu Jul 30, 7:00AM CDT

LEXINGTON, Mass. , July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 1.6100 (-6.40%)
Curis Announces Positive Emavusertib Update PR Newswire - Wed Jul 22, 6:00AM CDT

Updated Clinical Data in PCNSL

CRIS : 1.6100 (-6.40%)
Curis Consents First Six Patients in TakeAim CLL Study PR Newswire - Mon Jul 6, 8:30AM CDT

LEXINGTON, Mass. , July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...

CRIS : 1.6100 (-6.40%)
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split PR Newswire - Fri Jun 26, 8:42AM CDT

Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company reaffirms guidance for dosing of initial five patients by end of July 2026 with data expected December...

CRIS : 1.6100 (-6.40%)
Curis: Q1 Earnings Snapshot AP - Tue May 12, 3:10PM CDT

Curis: Q1 Earnings Snapshot

CRIS : 1.6100 (-6.40%)
Curis Provides First Quarter 2026 Business Update PR Newswire - Tue May 12, 3:00PM CDT

Management to host conference call today at 4:30 p.m. ET

CRIS : 1.6100 (-6.40%)
Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 PR Newswire - Tue May 5, 4:11PM CDT

LEXINGTON, Mass. , May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and...

CRIS : 1.6100 (-6.40%)
Curis: Q4 Earnings Snapshot AP - Thu Mar 19, 3:11PM CDT

Curis: Q4 Earnings Snapshot

CRIS : 1.6100 (-6.40%)

Barchart Exclusives

Bill Ackman Loves This Dividend Stock, But You Should Give It a Pass Barchart - Thu Aug 20, 6:30PM CDT
Bill Ackman's Pershing Square has held shares of Restaurant Brands International for over a decade. QSR stock has a healthy dividend yield of 3.4% but does not look like a compelling buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.